4:18 PM ET
8-K
Leadership Change
Macrogenics Leadership Change
MacroGenics appointed Dr. Michael Vasconcelles and Dr. Emil Kuriakose to its Board of Directors, effective October 30, 2026, increasing the board size to eleven members. Both appointees are independent directors with extensive oncology drug development experience and will serve on the company's Science and Technology Committee.